On May 12, 2022 Volastra Therapeutics, an oncology company focused on exploiting chromosomal instability (CIN) as a vulnerability for cancer cells, reported that members of its management team are scheduled to participate in a fireside chat at the 2022 Guggenheim Synthetic Lethality Day on May 16th at 11:30 a.m. ET (Press release, Volastra Therapeutics, MAY 12, 2022, View Source;utm_medium=rss&utm_campaign=volastra-therapeutics-announces-participation-in-2022-guggenheim-synthetic-lethality-day [SID1234614279]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A live webcast of the fireside chat can be accessed in the News and Views section of the company’s website at View Source A replay of the webcast will be archived on the company’s website for 90 days.